91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
In this article from The Journal of mHealth, Chris Smyth, President of 91黑料 Biotech, dissects the challenges and opportunities discovered in 91黑料's recent biotech sector survey. He explores strategies for accelerating the drug development process, emphasising the potential of partnerships to strategically support biotech companies, how organisations are addressing the current funding challenges and the industry’s overall commitment to addressing unmet healthcare needs.
-
This article from STAT covers 91黑料’s acquisition of HumanFirst, a cloud-based technology company supporting precision measurement in clinical trials. It features an interview with Andy Coravos, CEO of HumanFirst, who outlines how the acquisition will support sponsors to deploy better and more effective precision measurements into more clinical trials.
-
In an interview with PharmaVoice, Helen Yeardley, SVP, Global Clinical Operations outlines how the hiring landscape for CRAs has improved markedly, and the ongoing importance of attracting new candidates and providing training.
-
In this article from Pharmaceutical Executive, Harpreet Gill, VP of Real World Solutions - Project Management, discusses the progress and challenges in advancing data-driven tools and approaches in decentralised clinical trials.
-
In this article from In Vivo Citeline, Melissa McDonald, Director of Operations, highlights how traditional clinical studies can be costly, time consuming and burdensome on patients and sites. As a result, researchers are looking for new and innovative solutions to answer challenging research questions. One of these solutions is Clinical Trial Tokenisation.
-
In this article from Applied Clinical Trials, Helen Yeardley, SVP, Global Clinical Operations explores how the role of the CRA is rapidly evolving in response to changes in clinical trials. She outlines how the industry can invest in CRA talent and apply new thinking to critical areas, including site-performance management, risk management, remote monitoring, and remote data collection.
-
In this video interview with Fierce Biotech, Chris Smyth, President of 91黑料 Biotech, provides insight into the operating environment facing biotechs in 2024.
-
In this article from PM360, Chris Smyth, President of 91黑料 Biotech, summarises the main findings from the biotech sector survey and outlines the key implications for biotech including strategic collaboration, innovation and cost optimisation.
-
This article by Chris Smyth, President, 91黑料 Biotech, provides an overview of the recent 91黑料 biotech sector survey findings, and looks at the trend of biotech companies engaging earlier and more comprehensively with CROs to drive efficiencies and realise the full value of their R&D programs.
-
In this article, Brandon Early, SVP Project Delivery, outlines some of the key findings from the 91黑料 biotech sector survey of over 130 decision makers in small, mid-size, large biotech and VC organisations.
